PULMONX CORP
LUNG·745848101·US·Common Stock·Healthcare - Medical Devices-13D/G
LUNG (PULMONX CORP) is held by 72 institutional investors as of Q1 2026. Largest holders: PRIMECAP MANAGEMENT CO/CA/ ($6.1M), MORGAN STANLEY ($5.2M), BlackRock, Inc. ($3.4M). Net institutional sentiment: Mixed.
72
Holders
Avg rating(17 Elite)
$32.1M
Total Value
49% (78)
Fund Consensus
34 buying - 35 selling
Who's Trading
InsiderRSRadhakrishnan SrikanthSell $4KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $3KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $6KJun 1, 2026
InsiderRSRadhakrishnan SrikanthSell $9KJun 1, 2026
ActivistSMSoleus Capital Master Fund, L.P.6.5%Mar 9, 2026
InsiderFIFrench Glendon E. IIISell $4KMar 2, 2026
InsiderFIFrench Glendon E. IIISell $10KMar 2, 2026
InsiderFIFrench Glendon E. IIISell $83KMar 2, 2026
InsiderRBRose Geoffrey BeranSell $1KMar 2, 2026
13F: Insider & Congress:
Showing 1-20 of 78
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer